Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Diagnostic Interventional Cardiology Devices Market by Type (Transcatheter Angiography Devices, Intravascular Ultrasound (IVUS) Devices, Others, ), By Application (Hospitals, Clinics, Others, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Diagnostic Interventional Cardiology Devices Market by Type (Transcatheter Angiography Devices, Intravascular Ultrasound (IVUS) Devices, Others, ), By Application (Hospitals, Clinics, Others, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 171669 3300 Pharma & Healthcare 377 242 Pages 4.7 (34)
                                          

Market Overview:


The global diagnostic interventional cardiology devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in diagnostic interventional cardiology devices, and rising demand for minimally invasive procedures. The global diagnostic interventional cardiology devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into transcatheter angiography devices, intravascular ultrasound (IVUS) devices, and others. The transcatheter angiographydevices segment dominates this market owing to its high usage in various cardiac procedures such as percutaneous coronary intervention (PCI) and percutaneous transluminal coronary angioplasty (PTCA).Geographically,. North America dominates thismarket duetoits large population base with a high prevalence rate off cardiovascular diseasesand well-developed healthcare infrastructure.


Global Diagnostic Interventional Cardiology Devices Industry Outlook


Product Definition:


A diagnostic interventional cardiology device is a medical device used to diagnose and treat heart conditions. These devices include cardiac catheters, angiography systems, and stents. The importance of diagnostic interventional cardiology devices is that they allow physicians to diagnose and treat heart conditions without surgery.


Transcatheter Angiography Devices:


Transcatheter angiography (TSA) is a minimally invasive procedure used to evaluate coronary and peripheral artery disease. It allows real-time, three-dimensional imaging of blood vessels during the injection of contrast media into the bloodstream. The technology has been available for more than a decade; however, it was limited to only high-risk patients with severe heart conditions until recently.


Intravascular Ultrasound (IVUS) Devices:


Intravascular ultrasound (IVUS) devices are used for the noninvasive examination of blood vessels. It is a diagnostic tool that helps cardiology professionals to identify diseases and conditions in the body’s interior, such as kidney, liver or heart problems. IVUS uses high frequency sound waves to create images of blood vessels within the body.


         Global Intravascular Ultrasound Devices.


Application Insights:


Based on application, the global diagnostic interventional cardiology devices market is segmented into hospitals, clinics and other facilities, and others. The hospitals segment dominated the overall market in terms of revenue in 2017 owing to factors such as increasing prevalence of cardiac disorders coupled with rising geriatric population suffering from Cardiac Disorders (over 60 years). Moreover, this segment is also anticipated to grow at a lucrative rate during the forecast period due to introduction of technologically advanced products for diagnostics. For instance, In April 2018; catheter ablation system; CareFusion RFA II was launched by Curology which is an ablation system for patients with atrial fibrillation.


The clinics & other facilities segment are expected to witness significant growth over the forecast period owing to factors such as availability of advanced diagnostic technologies that help detect early signs of cardiovascular diseases at an affordable cost along with growing awareness about preventive healthcare measures among individuals across various age groups.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of CVDs, and presence of key players in this region. Moreover, growing adoption of advanced technologies and products is also expected to drive the regional market over the forecast period. Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness about diagnostic interventions for CVDs.


Major companies include Abbott; Boston Scientific Corporation; Medtronic plc.; St Jude Medical Inc.; Philips Healthcare; AngioDynamics Holdings Inc.; Percutaneous transluminal coronary angioplasty with catheter based on-site coronary intervention (CABG) system by EnSite Technologies LLC (U.S.


Growth Factors:


  • Increasing incidence of cardiovascular diseases (CVDs)
  • Rising geriatric population
  • Growing demand for minimally invasive procedures
  • Technological advancements in diagnostic and interventional cardiology devices
  • Rising healthcare expenditure

Scope Of The Report

Report Attributes

Report Details

Report Title

Diagnostic Interventional Cardiology Devices Market Research Report

By Type

Transcatheter Angiography Devices, Intravascular Ultrasound (IVUS) Devices, Others,

By Application

Hospitals, Clinics, Others,

By Companies

B. Braun Medical, Boston Scientific, Cook Medical, GE Healthcare, Medtronic, Merit Medical, Philips Healthcare, Siemens Healthineers, Abbott, Shimadzu Medical, Smiths Medical, Terumo, Toshiba

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

242

Number of Tables & Figures

170

Customization Available

Yes, the report can be customized as per your need.


Global Diagnostic Interventional Cardiology Devices Market Report Segments:

The global Diagnostic Interventional Cardiology Devices market is segmented on the basis of:

Types

Transcatheter Angiography Devices, Intravascular Ultrasound (IVUS) Devices, Others,

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Clinics, Others,

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. B. Braun Medical
  2. Boston Scientific
  3. Cook Medical
  4. GE Healthcare
  5. Medtronic
  6. Merit Medical
  7. Philips Healthcare
  8. Siemens Healthineers
  9. Abbott
  10. Shimadzu Medical
  11. Smiths Medical
  12. Terumo
  13. Toshiba

Global Diagnostic Interventional Cardiology Devices Market Overview


Highlights of The Diagnostic Interventional Cardiology Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Transcatheter Angiography Devices
    2. Intravascular Ultrasound (IVUS) Devices
    3. Others
  1. By Application:

    1. Hospitals
    2. Clinics
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Diagnostic Interventional Cardiology Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Diagnostic Interventional Cardiology Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Diagnostic interventional cardiology devices are medical devices used to diagnose and treat heart conditions. They can include stents, pacemakers, defibrillators, and other cardiac diagnostic tools.

Some of the major players in the diagnostic interventional cardiology devices market are B. Braun Medical, Boston Scientific, Cook Medical, GE Healthcare, Medtronic, Merit Medical, Philips Healthcare, Siemens Healthineers, Abbott, Shimadzu Medical, Smiths Medical, Terumo, Toshiba.

The diagnostic interventional cardiology devices market is expected to register a CAGR of 7.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Diagnostic Interventional Cardiology Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Diagnostic Interventional Cardiology Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Diagnostic Interventional Cardiology Devices Market - Supply Chain
   4.5. Global Diagnostic Interventional Cardiology Devices Market Forecast
      4.5.1. Diagnostic Interventional Cardiology Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Diagnostic Interventional Cardiology Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Diagnostic Interventional Cardiology Devices Market Absolute $ Opportunity

5. Global Diagnostic Interventional Cardiology Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Type
      5.3.1. Transcatheter Angiography Devices
      5.3.2. Intravascular Ultrasound (IVUS) Devices
      5.3.3. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Diagnostic Interventional Cardiology Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Clinics
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Diagnostic Interventional Cardiology Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Diagnostic Interventional Cardiology Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Diagnostic Interventional Cardiology Devices Demand Share Forecast, 2019-2026

9. North America Diagnostic Interventional Cardiology Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Clinics
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Type
      9.7.1. Transcatheter Angiography Devices
      9.7.2. Intravascular Ultrasound (IVUS) Devices
      9.7.3. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Diagnostic Interventional Cardiology Devices Demand Share Forecast, 2019-2026

10. Latin America Diagnostic Interventional Cardiology Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Clinics
      10.4.3. Others
    10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Type
      10.7.1. Transcatheter Angiography Devices
      10.7.2. Intravascular Ultrasound (IVUS) Devices
      10.7.3. Others
    10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Diagnostic Interventional Cardiology Devices Demand Share Forecast, 2019-2026

11. Europe Diagnostic Interventional Cardiology Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Clinics
      11.4.3. Others
    11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast y Type
      11.7.1. Transcatheter Angiography Devices
      11.7.2. Intravascular Ultrasound (IVUS) Devices
      11.7.3. Others
    11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Diagnostic Interventional Cardiology Devices Demand Share, 2019-2026

12. Asia Pacific Diagnostic Interventional Cardiology Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Clinics
      12.4.3. Others
    12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Type
      12.7.1. Transcatheter Angiography Devices
      12.7.2. Intravascular Ultrasound (IVUS) Devices
      12.7.3. Others
    12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Diagnostic Interventional Cardiology Devices Demand Share, 2019-2026

13. Middle East & Africa Diagnostic Interventional Cardiology Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Clinics
      13.4.3. Others
    13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Diagnostic Interventional Cardiology Devices Market Size and Volume Forecast by Type
      13.7.1. Transcatheter Angiography Devices
      13.7.2. Intravascular Ultrasound (IVUS) Devices
      13.7.3. Others
    13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Diagnostic Interventional Cardiology Devices Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Diagnostic Interventional Cardiology Devices Market: Market Share Analysis
   14.2. Diagnostic Interventional Cardiology Devices Distributors and Customers
   14.3. Diagnostic Interventional Cardiology Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. B. Braun Medical
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Boston Scientific
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Cook Medical
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. GE Healthcare
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Medtronic
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Merit Medical
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Philips Healthcare
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Siemens Healthineers
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Abbott
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Shimadzu Medical
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Smiths Medical
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Terumo
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Toshiba
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us